“[Use of Kovaltry® in patients with Hemophilia A: clinical and economical aspects from the pivotal clinical trials]” (2017) Farmeconomia. Health Economics and Therapeutic Pathways, 18(1). doi:10.7175/fe.v18i1.1284.